✦ LIBER ✦

Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients

✍ Scribed by Monique A Malouf; Prashant N Chhajed; Peter Hopkins; Marshall Plit; Jenny Turner; Allan R Glanville

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence, management, and outcome of po

✍ E.P Molmenti; D Nagata; J Roden; R Squires; H Molmenti; D Casey; C Fasola; M.Jam 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 52 KB

208Incidence, management, and outcome of

✍ MOLMENTI, E; FASOLA, C; RODEN, J; SQUIRES, R; NAGATA, D; JUNG, G; MARUBASHI, S; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

514: Donor (+)/recipient (-) EBV mismatc

✍ O. Elidemir; M.G. Schecter; E.D. McKenzie; J.S. Heinle; G.B. Mallory 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Anti-Fungal Prophylaxis in Lung Transpla

✍ Bhaskaran, A.; Mumtaz, K.; Singer, L.G.; Rotstein, C.; Husain, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Cytomegalovirus disease among donor-posi

✍ Dimitra Mitsani; M. Hong Nguyen; Eun J. Kwak; Fernanda P. Silveira; Aniket Vadne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Lower incidence of CMV infection and acu

✍ Johansson, Inger; Mårtensson, Gunnar; Nyström, Ulla; Nasic, Salmir; Andersson, R 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 260 KB